Zeev Bronfeld
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Zeev Bronfeld
Earlier roles on record: Chairman at Protalix BioTherapeutics, Inc. (PLX) until September 14, 2023. Protalix BioTherapeutics, Inc. reported in an 8-K filed September 12, 2023 that Zeev Bronfeld retired as Chairman of the Board, effective September 14, 2023.
“Zeev Bronfeld, the Company's current Chairman of the Board, has notified the Company of his retirement from the Company for personal reasons, effective as of the same date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-09-14
-
Start not stated–2023-09-14
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.